Stifel Financial Corp Fibrogen Inc Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Fibrogen Inc stock. As of the latest transaction made, Stifel Financial Corp holds 47,031 shares of FGEN stock, worth $16,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,031
Previous 46,861 0.36%
Holding current value
$16,460
Previous $41,000 56.1%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.33 - $1.26 $56 - $214
170 Added 0.36%
47,031 $18,000
Q2 2024

Aug 13, 2024
SELL
$0.89 - $2.36 $6,069 - $16,095
-6,820 Reduced 12.7%
46,861 $41,000
Q1 2024

May 13, 2024
BUY
$0.73 - $2.73 $8,805 - $32,929
12,062 Added 28.98%
53,681 $126,000
Q4 2023

Feb 12, 2024
SELL
$0.38 - $0.91 $19,480 - $46,651
-51,265 Reduced 55.19%
41,619 $37,000
Q3 2023

Nov 13, 2023
SELL
$0.79 - $2.83 $7,189 - $25,753
-9,100 Reduced 8.92%
92,884 $79,000
Q2 2023

Aug 14, 2023
BUY
$2.49 - $20.59 $44,224 - $365,698
17,761 Added 21.09%
101,984 $275,000
Q1 2023

May 12, 2023
SELL
$15.95 - $25.18 $183,026 - $288,940
-11,475 Reduced 11.99%
84,223 $1.57 Million
Q4 2022

Feb 13, 2023
SELL
$13.27 - $17.73 $105,204 - $140,563
-7,928 Reduced 7.65%
95,698 $1.53 Million
Q3 2022

Nov 14, 2022
BUY
$11.4 - $14.6 $53,500 - $68,517
4,693 Added 4.74%
103,626 $1.35 Million
Q2 2022

Aug 15, 2022
BUY
$7.94 - $12.96 $42,574 - $69,491
5,362 Added 5.73%
98,933 $1.05 Million
Q1 2022

May 13, 2022
BUY
$12.02 - $16.79 $9,844 - $13,751
819 Added 0.88%
93,571 $1.13 Million
Q4 2021

Feb 14, 2022
SELL
$9.93 - $15.39 $242,371 - $375,639
-24,408 Reduced 20.83%
92,752 $1.31 Million
Q3 2021

Nov 15, 2021
BUY
$10.18 - $26.64 $113,527 - $297,089
11,152 Added 10.52%
117,160 $1.2 Million
Q2 2021

Aug 13, 2021
SELL
$18.57 - $35.68 $143,527 - $275,770
-7,729 Reduced 6.8%
106,008 $2.82 Million
Q1 2021

May 14, 2021
BUY
$31.0 - $55.72 $324,074 - $582,496
10,454 Added 10.12%
113,737 $3.95 Million
Q4 2020

Feb 12, 2021
SELL
$37.09 - $48.97 $721,363 - $952,417
-19,449 Reduced 15.85%
103,283 $3.83 Million
Q3 2020

Nov 16, 2020
BUY
$40.47 - $45.5 $728,864 - $819,455
18,010 Added 17.2%
122,732 $5.05 Million
Q2 2020

Aug 14, 2020
SELL
$32.57 - $42.83 $351,137 - $461,750
-10,781 Reduced 9.33%
104,722 $4.25 Million
Q1 2020

May 14, 2020
BUY
$23.3 - $45.96 $15,634 - $30,839
671 Added 0.58%
115,503 $3.99 Million
Q4 2019

Feb 13, 2020
BUY
$34.58 - $48.06 $459,637 - $638,813
13,292 Added 13.09%
114,832 $4.93 Million
Q3 2019

Nov 13, 2019
SELL
$36.98 - $48.45 $156,573 - $205,137
-4,234 Reduced 4.0%
101,540 $3.75 Million
Q2 2019

Aug 14, 2019
BUY
$35.13 - $55.53 $85,365 - $134,937
2,430 Added 2.35%
105,774 $4.79 Million
Q1 2019

May 14, 2019
BUY
$42.83 - $59.91 $1.68 Million - $2.35 Million
39,270 Added 61.29%
103,344 $5.63 Million
Q4 2018

Feb 13, 2019
SELL
$37.97 - $60.16 $299,735 - $474,903
-7,894 Reduced 10.97%
64,074 $2.97 Million
Q3 2018

Nov 13, 2018
SELL
$56.3 - $67.25 $232,350 - $277,540
-4,127 Reduced 5.42%
71,968 $4.36 Million
Q2 2018

Aug 14, 2018
BUY
$44.9 - $64.95 $118,536 - $171,468
2,640 Added 3.59%
76,095 $4.76 Million
Q1 2018

May 11, 2018
BUY
$45.35 - $61.65 $193,735 - $263,368
4,272 Added 6.17%
73,455 $3.4 Million
Q4 2017

Feb 14, 2018
BUY
$41.95 - $60.1 $962,039 - $1.38 Million
22,933 Added 49.58%
69,183 $3.29 Million
Q3 2017

Nov 13, 2017
BUY
$33.4 - $53.9 $1.54 Million - $2.49 Million
46,250
46,250 $0

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email